Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.75 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | BLM | P54132 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.75 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.68 |
| ▸ | FAAH | O00519 | 1/20 | 0.68 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.68 |
| ▸ | CNR2 | P34972 | 1/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10609779 | 0.95 | CNR1 (0.88) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL886860 | 0.95 | CNR1 (0.88) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL30603566 | 0.95 | CNR1 (0.88) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL31030918 | 0.95 | CNR1 (0.88) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL3486418 | 0.91 | CNR1 (0.66) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL5031142 | 0.91 | CNR1 (0.76) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Oleoylethanolamide SCHEMBL239619 | 0.90 | CNR1 (0.91) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL5032805 | 0.90 | CNR1 (0.85) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| Oleoylethanolamide SCHEMBL177713 | 0.90 | CNR1 (0.91) | CNR1ALDH1A1HPGDTRPV1MEN1 | |
| SCHEMBL1109941 | 0.90 | CNR1 (0.91) | CNR1ALDH1A1HPGDTRPV1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10982174-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200040279-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2020-02-06 | — | — | US | disclosed |
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-20130288946-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130288946-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130217608-A1 | LAUNDRY DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY | 2013-08-22 | — | — | US | disclosed |
| US-20130217608-A1 | LAUNDRY DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY | 2013-08-22 | — | — | US | disclosed |
| WO-2012061094-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061110-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061108-A1 | LAUNDRY DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SGMS1, DEGS1, DGAT2 | CNR1 802/4885ALDH1A1 671/4885HPGD 1902/4885 |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | CNR1 830/4885ALDH1A1 656/4885HPGD 1901/4885 |
| US-10982174-B2 | Synergistic surfactant blends | HHAT, SQLE, SFN | CNR1 2358/4885ALDH1A1 2395/4885HPGD 4787/4885 |
| US-20200040279-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, SQLE, SFN | CNR1 2358/4885ALDH1A1 2395/4885HPGD 4787/4885 |
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | DEGS1, SGMS1, DGAT2 | CNR1 830/4885ALDH1A1 656/4885HPGD 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.